Breaking News Instant updates and real-time market news.

EBS

Emergent BioSolutions

$60.50

-1.06 (-1.72%)

10:02
08/29/18
08/29
10:02
08/29/18
10:02

Emergent deal for Adapt Pharma a 'bold' move with some risks, says Wells Fargo

Wells Fargo analyst David Maris said Emergent BioSolutions' agreement to acquire Adapt Pharma, the maker of Narcan nasal spray to treat opioid overdose, for about $735M is a "bold" move that some investors will like given the accretion and sales growth. However, some may see this as moving too far afield from its core business in biodefense and the deal may introduce overhang concerns about the duration of Narcan, added Maris. He raised his price target on Emergent shares to $65 from $61 and keeps a Market Perform rating on the stock.

  • 29

    Aug

  • 05

    Sep

  • 05

    Sep

  • 01

    Oct

EBS Emergent BioSolutions
$60.50

-1.06 (-1.72%)

06/13/18
06/13/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Liberty Global (LBTYA) initiated with a Sell at Berenberg. 2. Emergent BioSolutions (EBS) initiated with a Buy at Argus. 3. Nine Energy Services (NINE) initiated with a Strong Buy at Raymond James. 4. Can-Fite BioPharma (CANF) assumed with a Buy at H.C. Wainwright. 5. Control4 (CTRL) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/18
WELS
08/10/18
NO CHANGE
Target $61
WELS
Market Perform
Emergent BioSolutions acquisition of PaxVax an 'excellent fit,' says Wells Fargo
After Emergent BioSolutions agreed to acquire PaxVax for $270M, Wells Fargo analyst David Maris said the transaction "sounds as though it is an excellent fit" and he is adding $70M in revenues for 2019 and assuming growth of 10% per year, though he thinks that could be conservative given the possible sales synergies. He also raised his price target on Emergent BioSolutions shares to $61 from $56, though he keeps a Market Perform rating on the shares.
08/29/18
CANT
08/29/18
NO CHANGE
Target $62
CANT
Overweight
Emergent acquisition should bridge guidance gap, says Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes believes Emergent BioSolutions' acquisition of Adapt Pharma and its opioid overdose product, Narcan nasal spray, should help "bridge the Street's gap" from the current 2020 consensus revenue estimate of $830M to the company's guidance of $1B. The analyst keeps an Overweight rating on Emergent with a $62 price target.
08/29/18
CANT
08/29/18
NO CHANGE
Target $32
CANT
Overweight
Cantor sees value in Opiant after Emergent acquires Adapt Pharma
Cantor Fitzgerald analyst Brandon Folkes believes Emergent BioSolutions' (EBS) acquisition of Adapt Pharma underscores the potential for companies addressing the opioid overdose market. Opiant Pharmaceuticals (OPNT) is developing its own opioid overdose nasal spray, OPNT003, which could be of benefit in cases of synthetic opioid overdoses, such as with fentanyl, Folkes tells investors in a research note. He believes Opiant presents an attractive risk/reward at current share levels, "even if it captures only a portion of the growing market opioid overdose market." Folkes keeps an Overweight rating on the shares with a $32 price target.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/12/18
12/12
12:16
12/12/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$0.00

(0.00%)

, UBER

Uber

$0.00

(0.00%)

12:12
12/12/18
12/12
12:12
12/12/18
12:12
Periodicals
Uber controls most of U.S. ride-haling, but Lyft is growing faster, Recode says »

As ride sharing giants…

LYFT

Lyft

$0.00

(0.00%)

UBER

Uber

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$92.77

3.28 (3.67%)

, UAA

Under Armour

$20.38

-1.76 (-7.95%)

12:10
12/12/18
12/12
12:10
12/12/18
12:10
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been higher…

LOW

Lowe's

$92.77

3.28 (3.67%)

UAA

Under Armour

$20.38

-1.76 (-7.95%)

UA

Under Armour

$19.22

-1.65 (-7.91%)

DB

Deutsche Bank

$8.99

0.65 (7.79%)

TME

Tencent Music

$14.14

(0.00%)

CRZBY

Commerzbank

$0.00

(0.00%)

BHC

Bausch Health

$24.74

1.65 (7.15%)

SGYP

Synergy Pharmaceuticals

$0.14

-0.1959 (-57.62%)

URI

United Rentals

$111.01

9.12 (8.95%)

NBIX

Neurocrine

$68.85

-16.87 (-19.68%)

PLAY

Dave & Buster's

$45.77

-5.31 (-10.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Feb

  • 25

    Feb

  • 27

    Feb

  • 03

    Mar

  • 12

    Dec

12:10
12/12/18
12/12
12:10
12/12/18
12:10
General news
Euro$ interest rate futures are mostly lower »

Euro$ interest rate…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$268.38

4.25 (1.61%)

12:08
12/12/18
12/12
12:08
12/12/18
12:08
Periodicals
Former Trump lawyer Cohen sentenced to three years in prison, CNBC says »

Michael Cohen, the former…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$268.38

4.25 (1.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UA

Under Armour

$19.16

-1.71 (-8.19%)

12:00
12/12/18
12/12
12:00
12/12/18
12:00
Hot Stocks
Under Armour falls -8.2% »

Under Armour is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 03

    Mar

JE

Just Energy

$3.67

-0.38 (-9.38%)

12:00
12/12/18
12/12
12:00
12/12/18
12:00
Hot Stocks
Just Energy falls -9.4% »

Just Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

UGAZ

VelocityShares 3x Long Natural Gas ETN

$123.82

-15.49 (-11.12%)

12:00
12/12/18
12/12
12:00
12/12/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -11.1% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NX

Quanex

$13.98

1.63 (13.20%)

12:00
12/12/18
12/12
12:00
12/12/18
12:00
Hot Stocks
Quanex rises 13.4% »

Quanex is up 13.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCRH

Blue Capital

$6.17

0.58 (10.38%)

12:00
12/12/18
12/12
12:00
12/12/18
12:00
Hot Stocks
Blue Capital rises 13.6% »

Blue Capital is up 13.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

iShares MSCI Emerging Markets ETF

$40.61

0.85 (2.14%)

12:00
12/12/18
12/12
12:00
12/12/18
12:00
Options
Massive call spread in Emerging Markets ETF adjusts position »

Massive call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPA

Sparton

$18.29

5.19 (39.62%)

12:00
12/12/18
12/12
12:00
12/12/18
12:00
Hot Stocks
Sparton rises 39.4% »

Sparton is up 39.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYME

Zymeworks

$15.20

0.79 (5.48%)

11:58
12/12/18
12/12
11:58
12/12/18
11:58
Conference/Events
Zymeworks management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UAA

Under Armour

$20.30

-1.84 (-8.31%)

, UA

Under Armour

$19.10

-1.77 (-8.48%)

11:56
12/12/18
12/12
11:56
12/12/18
11:56
Recommendations
Under Armour, Under Armour analyst commentary  »

Under Armour targets…

UAA

Under Armour

$20.30

-1.84 (-8.31%)

UA

Under Armour

$19.10

-1.77 (-8.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 14

    Dec

  • 03

    Mar

NBIX

Neurocrine

$67.84

-17.885 (-20.86%)

11:55
12/12/18
12/12
11:55
12/12/18
11:55
Recommendations
Neurocrine analyst commentary  »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

GIB

CGI Group

$64.61

1.48 (2.34%)

11:55
12/12/18
12/12
11:55
12/12/18
11:55
Conference/Events
CGI Group management to meet with RBC Capital »

Group luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

11:55
12/12/18
12/12
11:55
12/12/18
11:55
General news
Fed funds futures have dropped on the surge in risk appetite »

Fed funds futures have…

11:55
12/12/18
12/12
11:55
12/12/18
11:55
Conference/Events
CLSA transportation analysts to hold a luncheon meeting »

Transportation Analysts…

FOR

Forestar Group

$14.99

0.21 (1.42%)

11:55
12/12/18
12/12
11:55
12/12/18
11:55
Conference/Events
Forestar Group to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SYF

Synchrony

$24.77

0.38 (1.56%)

11:53
12/12/18
12/12
11:53
12/12/18
11:53
Conference/Events
Synchrony management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LOW

Lowe's

$88.36

-1.13 (-1.26%)

11:53
12/12/18
12/12
11:53
12/12/18
11:53
Technical Analysis
Technical Take: Lowe's spikes after trading halt comes off »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

CASY

Casey's General Stores

$131.98

2.48 (1.92%)

11:52
12/12/18
12/12
11:52
12/12/18
11:52
Recommendations
Casey's General Stores analyst commentary  »

Casey's General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UXIN

Uxin

$7.91

2.01 (34.07%)

, BABA

Alibaba

$154.96

3.13 (2.06%)

11:49
12/12/18
12/12
11:49
12/12/18
11:49
Hot Stocks
China used car platform Uxin spikes over 30% after Taobao's Shopping Festival »

Uxin Limited (UXIN)…

UXIN

Uxin

$7.91

2.01 (34.07%)

BABA

Alibaba

$154.96

3.13 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$88.36

-1.13 (-1.26%)

11:48
12/12/18
12/12
11:48
12/12/18
11:48
Hot Stocks
Breaking Hot Stocks news story on Lowe's »

Lowe's trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

LOW

Lowe's

$88.36

-1.13 (-1.26%)

, HD

Home Depot

$174.91

2.66 (1.54%)

11:48
12/12/18
12/12
11:48
12/12/18
11:48
Technical Analysis
Technical Take: Home Depot spikes after Lowe's reiterates guidance, buybacks »

Shares of Home Depot (HD)…

LOW

Lowe's

$88.36

-1.13 (-1.26%)

HD

Home Depot

$174.91

2.66 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.